Digital tomosynthesis, or 3D mammography, has emerged as an effective breast imaging tool. 3D mammography combines conventional 2-dimensional mammogram images with additional 3-dimensional views. This enables enhanced views of breast tissue and research suggests 3D mammography offers several benefits over conventional 2D mammography.

Numerous genetic mutations are linked to increased risk for breast cancer. Genetic testing can identify these mutations and guide patient management decisions. Over the past decade, multi-gene panel tests have gained traction in clinical settings. These evaluate up to 43 breast cancer-related genes, compared with limited BRCA 1 and BRCA2 (BRCA1/2) tests.

Learning about breast cancer detection can potentially save your life. Early detection of breast cancer provides the best chance for optimal treatment outcomes. For the last several decades, breast cancer awareness initiatives have helped to reduce deaths from breast cancer. To ensure breast cancer patients receive appropriate care, educational efforts on breast cancer detection continue to remain relevant.

In recent years, many advancements have been made in our knowledge of the relationship between genetics and breast cancer. Tests are now available to help identify numerous genetic mutations that increase your risk for breast cancer. BRCA1 and BRCA2 are two genes that have been linked to increased risk for breast cancer. BRCA testing could potentially help you to make informed decisions regarding your breast health.

The results from a recent breast biopsy study reinforce the importance pathologists play in the management of breast diseases. Oncologists can have all the greatest tools at their disposal, but without an accurate diagnosis, these tools can be rendered useless.

A new study, published in The Journal of the American Medical Association (JAMA), provides further evidence towards this inclination. The March 2015 study suggests that pathologist frequently disagree on some high-risk breast lesions.

Breast Density Awareness Varies Among American Women

Awareness of breast tissue density issues varies among American women. Researchers from the Mayo Clinic in Rochester, Minnesota recently performed a national, cross-sectional survey to gauge differences in breast density knowledge across different patient populations.

It is essential that women and their physicians understand how breast density affects breast cancer risk and screening. As of December 2014, 18 states had passed breast density laws to help improve public knowledge surrounding breast density by requiring radiologists to inform patients when mammography reveals dense breast tissue.

Despite these developments, several recent surveys suggest that neither patients nor physicians fully understand the relationship between dense breast tissue, breast cancer risk, and breast cancer screening.

Despite large-scale campaigns to publicize the importance of breast cancer screening, a lot of faulty information regarding the mammogram exam is still being delivered to patients and sometimes interpreted as fact.

To gauge where gaps in knowledge about breast cancer screening are most commonly occurring, the Working Mother Research Institute recently surveyed more than 2,500 women aged 35 and older to see what they know. While the results contain good news, there are areas where physicians can better educate their patients.

Early research has shown that 3D mammography can improve breast cancer detection rates and reduce false-positive rates. In women with dense breast tissue, which can mask cancers on conventional mammography, 3D mammography is emerging as a valuable supplemental screening tool.

Inherited genetic mutations can increase a woman’s risk of developing breast cancer. For instance, a mutation in two of the better-understood genes linked to a substantial increased risk of breast cancer, the BRCA1 and BRCA2 genes, account for up to: